Recombinant NFIX antibody (Center)
Quick Overview for Recombinant NFIX antibody (Center) (ABIN7826100)
Target
See all NFIX (MLZE) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- Center
-
Purpose
- NFIX antibody (HMV329)
-
Immunogen
- Recombinant protein encompassing a sequence within the center region of human NFIX. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- IHC 1:100-1:200
-
Comment
-
Positive Control: Placenta: A moderate to strong nuclear NFIX staining should be seen in stromal cells while trophoblast cells should remain NFIX negative.
Product Description/Background: NFIX antibody validated for immunohistochemistry on 76 different Normal Tissues
Negative Control: Placenta: Trophoblast cells should remain NFIX negative while a moderate to strong nuclear NFIX staining should be seen in stromal cells.
-
Protocol
- Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:150 at 37 °C for 60 minutes.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Antibody with azide - store at 2 to 8 C. Antibody without azide - store at -20 to -80 C. Antibody is stable for 24 months. Non- hazardous. No MSD required.
-
Expiry Date
- 24 months
-
-
- NFIX (MLZE) (Nuclear Factor I/X (MLZE))
-
Alternative Name
- NFIX
-
UniProt
- Q14938
-
Pathways
- Skeletal Muscle Fiber Development
Target
-